1. Home
  2. NEO vs FOR Comparison

NEO vs FOR Comparison

Compare NEO & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$12.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$24.33

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
FOR
Founded
2001
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
1999
2007

Fundamental Metrics

Financial Performance
Metric
NEO
FOR
Price
$12.46
$24.33
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
$11.38
$31.25
AVG Volume (30 Days)
1.7M
149.9K
Earning Date
10-28-2025
01-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.29
Revenue
$709,162,000.00
$1,662,400,000.00
Revenue This Year
$10.90
$0.58
Revenue Next Year
$9.88
$8.73
P/E Ratio
N/A
$7.47
Revenue Growth
10.10
10.14
52 Week Low
$4.72
$18.00
52 Week High
$19.12
$29.44

Technical Indicators

Market Signals
Indicator
NEO
FOR
Relative Strength Index (RSI) 67.58 39.73
Support Level $11.46 $26.27
Resistance Level $12.19 $27.65
Average True Range (ATR) 0.40 0.84
MACD -0.03 -0.19
Stochastic Oscillator 85.90 8.49

Price Performance

Historical Comparison
NEO
FOR

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

Share on Social Networks: